Delayed Safety Outcomes After Therapeutic Genome Editing: A Scoping Review of Clonal Dynamics, Genomic Alterations, Follow-Up Duration, and Adverse-Event Attribution in Clinical Translation
International Journal of Pharmaceutical Research and Allied Sciences · 2026 · 15 (4) · 185-195
DOI: 10.51847/d0kcg1no6b ↗Kurz gefasst
Scoping Review in der Zeitschrift International Journal of Pharmaceutical Research and Allied Sciences, 2026. Verfasst von Aisha Rahman und 5 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rahman, A., Weber, J., Brenner, M., Tanaka, Y., Okafor, G., & Bello, A. (2026). Delayed Safety Outcomes After Therapeutic Genome Editing: A Scoping Review of Clonal Dynamics, Genomic Alterations, Follow-Up Duration, and Adverse-Event Attribution in Clinical Translation. International Journal of Pharmaceutical Research and Allied Sciences, 15(4), 185-195. https://doi.org/10.51847/d0kcg1no6b
Vancouver
Rahman A, Weber J, Brenner M, Tanaka Y, Okafor G, Bello A. Delayed Safety Outcomes After Therapeutic Genome Editing: A Scoping Review of Clonal Dynamics, Genomic Alterations, Follow-Up Duration, and Adverse-Event Attribution in Clinical Translation. International Journal of Pharmaceutical Research and Allied Sciences. 2026;15(4):185-195. doi:10.51847/d0kcg1no6b
BibTeX
@article{Rahman2026,
author = {Rahman, Aisha and Weber, Julia and Brenner, Michael and Tanaka, Yuki and Okafor, Grace and Bello, Aisha},
title = {Delayed Safety Outcomes After Therapeutic Genome Editing: A Scoping Review of Clonal Dynamics, Genomic Alterations, Follow-Up Duration, and Adverse-Event Attribution in Clinical Translation},
journal = {International Journal of Pharmaceutical Research and Allied Sciences},
year = {2026},
volume = {15},
number = {4},
pages = {185--195},
doi = {10.51847/d0kcg1no6b}
}
EUVIMED